Regional differences in prescription of drugs with proven efficacy in reduction of mortality in secondary prevention of cardiovascular events

Arkadiusz Pietrasik; Marta E. Starczewska; Renata Główczyńska; Krzysztof J. Filipiak; Maciej Łatek; Grzegorz Opolski

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

6/2005
vol. 8

Send email

Copy url:

abstract:

Regional differences in prescription of drugs with proven efficacy in reduction of mortality in secondary prevention of cardiovascular events

Arkadiusz Pietrasik

,

Marta E. Starczewska

,

Renata Główczyńska

,

Krzysztof J. Filipiak

,

Maciej Łatek

,

Grzegorz Opolski

Przew Lek 2005; 6: 48-51

Online publish date: 2005/09/19

View full text Get citation

Current paper describes regional differences in prescription of drugs, with proven efficacy in reduction of mortality, in secondary prevention of cardiovascular diseases.
Data were gathered alongside POLKARD-SPOK survey, which was performed, under the auspices of the Ministry of Health in Poland, to distinguish risk factors and describe their management in relation to current guidelines in prevention of cardiovascular diseases, in primary care practice. POLKARD-SPOK reveled significant regional differences in frequency of prescribed drugs such as aspirin, beta-blockers, ACE inhibitors and statins in primary care settings. In accordance to present secondary prevention guidelines usage of these drugs remains insufficient.

keywords:

Regional differences in prescription of drugs with proven efficacy in reduction of mortality in secondary prevention of cardiovascular events

Arkadiusz Pietrasik , Marta E. Starczewska , Renata Główczyńska , Krzysztof J. Filipiak , Maciej Łatek , Grzegorz Opolski

secondary prevention, pharmacotherapy

Arkadiusz Pietrasik

,

Marta E. Starczewska

,

Renata Główczyńska

,

Krzysztof J. Filipiak

,

Maciej Łatek

,

Grzegorz Opolski